In fact, sulforaphane administration may prevent T2DM-induced cardiomyopathy by reversing the oxidative stress-induced inhibition of the LKB1/AMPK/PGC-1α signaling pathway [194]. Here, PPARGC1A is linked to type 2 diabetes mellitus.